PHG
Koninklijke Philips NV
$
28.270
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
28.285
Open
27.980
VWAP
28.19
Vol
939.05K
Mkt Cap
26.87B
Low
27.920
Amount
26.48M
EV/EBITDA(TTM)
10.75
Total Shares
937.26M
EV
29.47B
EV/OCF(TTM)
26.67
P/S(TTM)
1.25
Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q2
3.66B
-10.62%
0.438
-17.83%
5.05B
+0.16%
0.291
-10.46%
Estimates Revision
The market is revising Downward the revenue expectations for Koninklijke Philips N.V. (PHG) for FY2025, with the revenue forecasts being adjusted by -1.62% over the past three months. During the same period, the stock price has changed by 28.15%.
Revenue Estimates for FY2025
Revise Downward
-1.62%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+6.49%
In Past 3 Month
Stock Price
Go Up
+28.15%
In Past 3 Month
Valuation Metrics
The current forward P/E ratio for Koninklijke Philips NV (PHG.N) is 16.45, compared to its 5-year average forward P/E of 17.12. For a more detailed relative valuation and DCF analysis to assess Koninklijke Philips NV 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
17.12
Current PE
16.45
Overvalued PE
23.72
Undervalued PE
10.53
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Fair
5Y Average EV/EBITDA
9.88
Current EV/EBITDA
9.84
Overvalued EV/EBITDA
12.20
Undervalued EV/EBITDA
7.55
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
1.31
Current PS
1.22
Overvalued PS
1.81
Undervalued PS
0.80
Financials
Annual
Quarterly
FY2025Q2
YoY :
+2.36%
4.92B
Total Revenue
FY2025Q2
YoY :
+18.38%
552.93M
Operating Profit
FY2025Q2
YoY :
-35.37%
281.00M
Net Income after Tax
FY2025Q2
YoY :
-46.15%
0.28
EPS - Diluted
FY2025Q2
YoY :
-438.09%
258.34M
Free Cash Flow
FY2025Q2
YoY :
+3.99%
46.36
Gross Profit Margin - %
FY2025Q2
YoY :
-58.52%
2.41
FCF Margin - %
FY2025Q2
YoY :
-19.94%
5.58
Net Margin - %
FY2025Q2
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 30126.47% over the last quarter.
Sold
0-3
Months
26.6M
Volume
1
3-6
Months
87.9K
Volume
1
6-9
Months
545.9K
Volume
1
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
1
2.6M
Volume
Months
6-9
3
88.4K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
PHG News & Events
Events Timeline
2025-09-15 (ET)
2025-09-15
05:02:29
Philips to prolong two forward contracts for 2 million shares under incentive plan
2025-09-11 (ET)
2025-09-11
09:24:29
Stifel Calls Masimo's Renewal and Expansion with Philips "Clearly Positive News"
2025-09-11
08:14:30
Philips and Masimo Reveal Extended Multi-Year Strategic Partnership
Sign Up For More Events
Sign Up For More Events
News
7.5
09-11NewsfilterMasimo Expands Strategic Partnership with Philips
7.5
09-11NewsfilterPhilips and Masimo Join Forces to Enhance Patient Monitoring Technology Access
5.0
09-04NewsfilterPhilips Introduces Advanced Telemetry Platform for Cardiac Monitoring, Ensuring Continuous Connectivity Across Healthcare Facilities
Sign Up For More News
People Also Watch
EXPE
Expedia Group Inc
221.920
USD
-1.45%
TPG
TPG Inc
63.730
USD
+1.77%
ROL
Rollins Inc
55.730
USD
-0.73%
WAT
Waters Corp
306.380
USD
+0.89%
IX
ORIX Corp
26.860
USD
-0.37%
HUBB
Hubbell Inc
440.100
USD
+1.58%
WBD
Warner Bros Discovery Inc
18.700
USD
+3.95%
RKT
Rocket Companies Inc
21.140
USD
-0.09%
GFS
GlobalFoundries Inc
33.270
USD
+3.32%
PHM
Pultegroup Inc
134.100
USD
0.00%
FAQ
What is Koninklijke Philips NV (PHG) stock price today?
The current price of PHG is 28.27 USD — it has increased 1.25 % in the last trading day.
What is Koninklijke Philips NV (PHG)'s business?
What is the price predicton of PHG Stock?
What is Koninklijke Philips NV (PHG)'s revenue for the last quarter?
What is Koninklijke Philips NV (PHG)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Koninklijke Philips NV (PHG)'s fundamentals?
How many employees does Koninklijke Philips NV (PHG). have?